Spots Global Cancer Trial Database for MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ

Official Title: Ductal Carcinoma in Situ: Protocol Evaluating the Assessment of Extension of Disease by MRI

Study ID: NCT00874458

Conditions

Breast Cancer

Interventions

magnetic resonance imaging

radiomammography

ultrasound imaging

Study Description

Brief Summary: RATIONALE: Diagnostic procedures, such as MRI, may help find ductal carcinoma in situ and find out how far the disease has spread. PURPOSE: This clinical trial is studying how well MRI works in assessing tumor size in women with ductal carcinoma in situ.

Detailed Description: OBJECTIVES: Primary * Assess the contribution of MRI in accurately determining tumor size in women with ductal breast carcinoma in situ (DCIS). Secondary * Evaluate the sensitivity of MRI in detecting DCIS. * Evaluate the contribution of mammography in accurately determining tumor size. * Compare the contribution of MRI vs mammography in assessing tumor extension. * Compare the contribution of MRI vs mammography in assessing dense breasts. * Evaluate the morphology of DCIS by MRI. * Evaluate the curve of dynamic MRI in assessing DCIS. * Evaluate the impact of nuclear grade of DCIS by MRI. * Evaluate the rate of revision surgery. OUTLINE: Patients undergo clinical examination, mammography, ultrasound imaging, unilateral breast MRI, and tissue sampling.